Caitlin Cronin

Stock Analyst at Canaccord Genuity

(3.80)
# 1,835
Out of 4,396 analysts
184
Total ratings
47.1%
Success rate
7.6%
Average return

Stocks Rated by Caitlin Cronin

Smith & Nephew
May 11, 2026
Maintained: Hold
Price Target: $32$30
Current: $31.32
Upside: -4.21%
Globus Medical
May 8, 2026
Reiterated: Buy
Price Target: $90$115
Current: $82.52
Upside: +39.36%
Zimmer Biomet Holdings
Apr 24, 2026
Maintained: Hold
Price Target: $93
Current: $89.63
Upside: +3.76%
Enovis
Feb 27, 2026
Reiterated: Buy
Price Target: $50
Current: $23.96
Upside: +108.68%
Bioventus
Dec 17, 2025
Maintained: Buy
Price Target: $15
Current: $9.20
Upside: +63.04%
Orthofix Medical
Dec 16, 2025
Maintained: Buy
Price Target: $24
Current: $9.87
Upside: +143.16%
TELA Bio
Dec 16, 2025
Maintained: Buy
Price Target: $4
Current: $0.9352
Upside: +327.72%
Vericel
Nov 6, 2025
Maintained: Buy
Price Target: $58
Current: $36.94
Upside: +57.01%
Alphatec Holdings
Oct 31, 2025
Reiterated: Buy
Price Target: $20$25
Current: $8.26
Upside: +202.66%
Stryker
Oct 31, 2025
Reiterated: Buy
Price Target: $435
Current: $314.01
Upside: +38.53%
Reiterated: Hold
Price Target: $14$16
Current: $13.56
Upside: +17.99%
Reiterated: Buy
Price Target: $5
Current: $3.99
Upside: +25.31%
Reiterated: Buy
Price Target: $24
Current: $42.87
Upside: -44.02%
Maintained: Buy
Price Target: $25$26
Current: $15.53
Upside: +67.42%
Downgraded: Hold
Price Target: $12
Current: $0.52
Upside: n/a